Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSB | P07858 | 17/20 | 1.00 |
| ▸ | CTSL | P07711 | 16/20 | 1.00 |
| ▸ | CTSF | Q9UBX1 | 9/20 | 1.00 |
| ▸ | CTSK | P43235 | 11/20 | 0.78 |
| ▸ | CTSS | P25774 | 9/20 | 0.78 |
| ▸ | CTSV | O60911 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2156015 | 1.00 | CTSB (1.00) | CTSBCTSLCTSFCTSKCTSS | |
| SCHEMBL22733937 | 1.00 | CTSB (1.00) | CTSBCTSLCTSFCTSKCTSS | |
| SCHEMBL2156891 | 0.94 | CTSB (0.89) | CTSBCTSLCTSFCTSKCTSS | |
| SCHEMBL2157045 | 0.93 | CTSB (0.87) | CTSBCTSLCTSFCTSKCTSS | |
| SCHEMBL22733994 | 0.90 | CTSB (0.81) | CTSBCTSLCTSFCTSKCTSS | |
| SCHEMBL22733992 | 0.90 | CTSB (0.81) | CTSBCTSLCTSFCTSKCTSS | |
| SCHEMBL22733995 | 0.90 | CTSB (0.81) | CTSBCTSLCTSFCTSKCTSS | |
| SCHEMBL24199879 | 0.88 | CTSB (0.79) | CTSBCTSLCTSFCTSKCTSS | |
| SCHEMBL22733952 | 0.88 | CTSB (0.79) | CTSBCTSLCTSFCTSKCTSS | |
| SCHEMBL22733950 | 0.88 | CTSB (0.79) | CTSBCTSLCTSFCTSKCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4046987-B1 | CATHEPSIN INHIBITORS | ACADEMISCH ZIEKENHUIS LEIDEN (NL) | 2025-08-27 | — | — | EP | disclosed |
| US-12371400-B2 | Cathepsin inhibitors | ACADEMISCH ZIEKENHUIS LEIDEN (h.o.d.n. LUMC) (NL) | 2025-07-29 | — | — | US | disclosed |
| US-20240182409-A1 | CATHEPSIN INHIBITORS | ACADEMISCH ZIEKENHUIS LEIDEN (h.o.d.n. LUMC) (NL) | 2024-06-06 | — | — | US | disclosed |
| US-11820734-B2 | Cathepsin inhibitors | ACADEMISCH ZIEKENHUIS LEIDEN (h.o.d.n. LUMC) (NL) | 2023-11-21 | — | — | US | disclosed |
| EP-4046987-A1 | CATHEPSIN INHIBITORS | Academisch Ziekenhuis Leiden (h.o.d.n. LUMC) (NL) | 2022-08-24 | — | — | EP | disclosed |
| US-20220227705-A1 | CATHEPSIN INHIBITORS | ACADEMISCH ZIEKENHUIS LEIDEN (h.o.d.n. LUMC) (NL) | 2022-07-21 | — | — | US | disclosed |
| EP-3720840-B1 | CATHEPSIN INHIBITORS | ACADEMISCH ZIEKENHUIS LEIDEN (NL) | 2022-01-19 | — | — | EP | disclosed |
| US-11174224-B2 | Cathepsin inhibitors | ACADEMISCH ZIEKENHUIS LEIDEN (h.o.d.n. LUMC) (NL) | 2021-11-16 | — | — | US | disclosed |
| US-20200385341-A1 | CATHEPSIN INHIBITORS | ACADEMISCH ZIEKENHUIS LEIDEN (h.o.d.n. LUMC) (NL) | 2020-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11820734-B2 | Cathepsin inhibitors | CTSK, CTSZ, CTSF | CTSB 5/4885CTSL 12/4885CTSF 3/4885 |
| US-12371400-B2 | Cathepsin inhibitors | CTSK, CTSZ, CTSF | CTSB 5/4885CTSL 12/4885CTSF 3/4885 |
| US-20200385341-A1 | CATHEPSIN INHIBITORS | CTSK, CTSZ, CTSF | CTSB 5/4885CTSL 12/4885CTSF 3/4885 |
| US-11174224-B2 | Cathepsin inhibitors | CTSK, CTSZ, CTSF | CTSB 5/4885CTSL 12/4885CTSF 3/4885 |
| US-20220227705-A1 | CATHEPSIN INHIBITORS | CTSK, CTSZ, CTSF | CTSB 5/4885CTSL 12/4885CTSF 3/4885 |
| US-20240182409-A1 | CATHEPSIN INHIBITORS | CTSK, CTSZ, CTSF | CTSB 5/4885CTSL 12/4885CTSF 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.